comparemela.com

Latest Breaking News On - Therapeuticsmd - Page 1 : comparemela.com

TherapeuticsMD (NASDAQ:TXMD) Coverage Initiated by Analysts at StockNews.com

StockNews.com assumed coverage on shares of TherapeuticsMD (NASDAQ:TXMD – Free Report) in a research note released on Thursday. The firm issued a hold rating on the stock. TherapeuticsMD Trading Down 0.5 % Shares of TXMD opened at $1.86 on Thursday. The stock has a fifty day moving average of $2.22 and a two-hundred day moving […]

United-states
Mayne-pharma
Therapeuticsmd-inc
Therapeuticsmd-company-profile
Exchange-commission
Capital-management
Nasdaq
Free-report
Get-free-report
Therapeuticsmd
Nasdaq-txmd
Txmd

StockNews.com Begins Coverage on TherapeuticsMD (NASDAQ:TXMD)

StockNews.com assumed coverage on shares of TherapeuticsMD (NASDAQ:TXMD – Free Report) in a research report sent to investors on Monday. The firm issued a hold rating on the stock. TherapeuticsMD Trading Down 0.9 % TherapeuticsMD stock opened at $2.23 on Monday. The business’s 50-day simple moving average is $2.31 and its two-hundred day simple moving […]

United-states
Mayne-pharma
Therapeuticsmd-company-profile
Therapeuticsmd-inc
Principal-financial-group-inc
Charles-schwab-investment-management-inc
Free-report
Street-corp
Financial-group
Schwab-investment-management
Rhumbline-advisers
Get-free-report

TherapeuticsMD (NASDAQ:TXMD) Receives New Coverage from Analysts at StockNews.com

Research analysts at StockNews.com started coverage on shares of TherapeuticsMD (NASDAQ:TXMD – Get Free Report) in a research note issued to investors on Monday. The firm set a “hold” rating on the stock. TherapeuticsMD Stock Performance Shares of NASDAQ:TXMD opened at $2.27 on Monday. TherapeuticsMD has a twelve month low of $1.95 and a twelve […]

United-states
Canada
Marland-walker
Mayne-pharma
Therapeuticsmd-inc
Capital-management
Goldman-sachs-group-inc
Royal-bank
Renaissance-technologies
Tejara-capital-ltd
Nasdaq
Get-free-report

TherapeuticsMD (NASDAQ:TXMD) Research Coverage Started at StockNews.com

StockNews.com started coverage on shares of TherapeuticsMD (NASDAQ:TXMD – Free Report) in a report released on Tuesday morning. The brokerage issued a hold rating on the stock. TherapeuticsMD Stock Up 0.9 % NASDAQ TXMD opened at $2.26 on Tuesday. The company has a 50 day moving average of $2.30 and a 200-day moving average of […]

United-states
Mayne-pharma
Marland-walker
Therapeuticsmd-company-profile
Geode-capital-management
Therapeuticsmd-inc
Millennium-management
Tejara-capital-ltd
Charles-schwab-investment-management-inc
Free-report
Get-free-report
Capital-ltd

TherapeuticsMD (NASDAQ:TXMD) Coverage Initiated at StockNews.com

StockNews.com began coverage on shares of TherapeuticsMD (NASDAQ:TXMD – Free Report) in a research report sent to investors on Tuesday. The brokerage issued a hold rating on the stock. TherapeuticsMD Price Performance TXMD opened at $2.24 on Tuesday. TherapeuticsMD has a 52 week low of $1.95 and a 52 week high of $5.35. The business’s […]

United-states
Mayne-pharma
Marland-walker
Jpmorgan-chase-co
Therapeuticsmd-inc
Securities-exchange-commission
Principal-financial-group-inc
Free-report
Get-free-report
Exchange-commission
Financial-group
Street-corp

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.